The development of CD4+ T effector cells during the type 2 immune response

被引:25
作者
Gause, WC [1 ]
Ekkens, M
Nguyen, D
Mitro, V
Liu, Q
Finkelman, FD
Greenwald, RJ
Urban, JF
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH USA
[3] USDA, Immunol Dis Resistance Lab, Inst Livestock & Poultry Sci, Beltsville, MD 20705 USA
关键词
CD4(+) T cell; costimulation; CD28; B7; type; 2; Th2; cytokines; immune response;
D O I
10.1007/BF02786507
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple pathways may be involved in the development of interleukin 4 (IL-4) producing T helper (Th) cells and the associated type 2 immune response. Increasing evidence suggests that the strength of signals delivered to the T cell may favor the development of the type 2 response. In contrast, antigen-presenting cell- (APC) derived stimuli produced following pattern recognition receptor binding during the innate response promotes the development of interferon-gamma (IFN-gamma) producing cells and the associated type 1 immune response. In many cases, the balance between increased signaling strength and the innate response may determine whether the type 2 response develops. T cell receptor (TCR), CD4, and costimulatory molecule interactions may all contribute to signal strength, but the type 2 immune response may be particularly dependent on the availability of coreceptor and costimulatory molecule interactions. B7 ligand interactions are required for the development of the type 2 immune response and interaction of CD28 with either B7-1 or B7-2 can provide sufficient signals for its initiation. In B7-2-deficient mice, the initial type 2 immune response is intact, but the response is not sustained, suggesting that B7-2 is important at later stages of the type 2 immune response. The roles of CD28 and CTLA-4 during the type 2 response remain unclear. The type 2 response to infectious pathogens is pronounced in CD28(-/-) mice, suggesting that. other costimulatory molecule interactions can substitute for CD28 for the development of IL-4 producing T cells and the associated type 2 immune response.
引用
收藏
页码:55 / 65
页数:11
相关论文
共 66 条
[1]  
Alegre ML, 1998, J IMMUNOL, V161, P3347
[2]   LOW-LEVEL INFECTION WITH TRICHURIS-MURIS SIGNIFICANTLY AFFECTS THE POLARIZATION OF THE CD4 RESPONSE [J].
BANCROFT, AJ ;
ELSE, KJ ;
GRENCIS, RK .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3113-3118
[3]   Helper T cell differentiation is controlled by the cell cycle [J].
Bird, JJ ;
Brown, DR ;
Mullen, AC ;
Moskowitz, NH ;
Mahowald, MA ;
Sider, JR ;
Gajewski, TF ;
Wang, CR ;
Reiner, SL .
IMMUNITY, 1998, 9 (02) :229-237
[4]   ESTABLISHMENT OF STABLE, CELL-MEDIATED-IMMUNITY THAT MAKES SUSCEPTIBLE MICE RESISTANT TO LEISHMANIA-MAJOR [J].
BRETSCHER, PA ;
WEI, GJ ;
MENON, JN ;
BIELEFELDTOHMANN, H .
SCIENCE, 1992, 257 (5069) :539-542
[5]   A role for CD4 in peripheral T cell differentiation [J].
Brown, DR ;
Moskowitz, NH ;
Killeen, N ;
Reiner, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :101-107
[6]   beta 2-microglobulin-dependent NK1.1(+) T cells are not essential for T helper cell 2 immune responses [J].
Brown, DR ;
Fowell, DJ ;
Corry, DB ;
Wynn, TA ;
Moskowitz, NH ;
Cheever, AW ;
Locksley, RM ;
Reiner, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1295-1304
[7]   Limited role of CD28-mediated signals in T helper subset differentiation [J].
Brown, DR ;
Green, JM ;
Moskowitz, NH ;
Davis, M ;
Thompson, CB ;
Reiner, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :803-810
[8]   Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response [J].
Brown, JA ;
Titus, RG ;
Nabavi, N ;
Glimcher, LH .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1303-1308
[9]   EXTENT OF T-CELL RECEPTOR LIGATION CAN DETERMINE THE FUNCTIONAL-DIFFERENTIATION OF NAIVE CD4(+) T-CELLS [J].
CONSTANT, S ;
PFEIFFER, C ;
WOODARD, A ;
PASQUALINI, T ;
BOTTOMLY, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1591-1596
[10]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322